WallStreetZenWallStreetZen

NYSE: ABBV
AbbVie Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ABBV

Based on 8 analysts offering 12 month price targets for AbbVie Inc.
Min Forecast
$113.00-18.07%
Avg Forecast
$145.88+5.77%
Max Forecast
$172.00+24.71%

Should I buy or sell ABBV stock?

Based on 8 analysts offering ratings for AbbVie Inc.
Strong Buy
Strong Buy
4 analysts 50%
Buy
2 analysts 25%
Hold
2 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABBV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 4%
4
Strong BuyMaintains$142.00+2.96%2022-01-24
Barclays
Bottom 12%
12
HoldMaintains$133.00-3.57%2022-01-20
BMO Capital
Bottom 19%
19
BuyMaintains$153.00+10.93%2022-01-12Find out why
Mizuho
Bottom 5%
5
Strong BuyMaintains$154.00+11.66%2022-01-05Find out why
Goldman Sachs
Top 27%
74
HoldInitiates Coverage On$113.00-18.07%2021-12-17
Wells Fargo
Top 20%
81
Strong BuyInitiates Coverage On$165.00+19.63%2021-12-09
Societe Generale
Bottom 46%
46
Strong BuyUpgrades$172.00+24.71%2021-11-23
SVB Leerink
Top 28%
73
BuyMaintains$135.00-2.12%2021-11-01
Anonymous
SVB Leerink
BuyMaintains$144.00+4.41%2021-03-30

1 of 1

Forecast return on equity

Is ABBV forecast to generate an efficient return?
Company
175.18%
Industry
75.76%
Market
58.24%
ABBV's Return on Equity is... subscribe to Premium to read more.
Forecast

Forecast return on assets

Is ABBV forecast to generate an efficient return on assets?
Company
15.95%
Industry
17.32%
ABBV is forecast to generate... subscribe to Premium to read more.
Forecast

ABBV earnings per share forecast

What is ABBV's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$14.07+239.04%
Avg 2 year Forecast
$12.21+194.22%
Avg 3 year Forecast
$12.61+203.86%
ABBV's earnings are forecast to... subscribe to Premium to read more.
Forecast

ABBV revenue forecast

What is ABBV's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$59.9B+8.55%
Avg 2 year Forecast
$56.3B+2.03%
Avg 3 year Forecast
$56.7B+2.71%
ABBV's revenue is forecast to... subscribe to Premium to read more.
Forecast

ABBV earnings growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
41.78%
Industry
24.54%
Market
18.83%
ABBV's earnings are forecast to... subscribe to Premium to read more.
Forecast
ABBV's earnings are forecast to... subscribe to Premium to read more.
Forecast
ABBV's earnings are forecast to... subscribe to Premium to read more.
Forecast

ABBV revenue growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
0.22%
Industry
4.17%
Market
11.5%
ABBV's revenues are forecast to... subscribe to Premium to read more.
Forecast
ABBV's revenues are forecast to... subscribe to Premium to read more.
Forecast

AbbVie Stock Forecast FAQ

Is AbbVie Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock.

Out of 8 analysts, 4 (50%) are recommending ABBV as a Strong Buy, 2 (25%) are recommending ABBV as a Buy, 2 (25%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell.

What is ABBV's earnings growth forecast for 2022-2024?

(NYSE: ABBV) AbbVie's forecast annual earnings growth rate of 41.78% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 24.54%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.83%.

AbbVie's earnings in 2022 is $7,534,000,000.On average, 7 Wall Street analysts forecast ABBV's earnings for 2022 to be $24,874,078,143, with the lowest ABBV earnings forecast at $24,538,180,854, and the highest ABBV earnings forecast at $25,634,266,743. On average, 5 Wall Street analysts forecast ABBV's earnings for 2023 to be $21,585,820,478, with the lowest ABBV earnings forecast at $20,914,025,901, and the highest ABBV earnings forecast at $22,505,118,319.

In 2024, ABBV is forecast to generate $22,292,972,664 in earnings, with the lowest earnings forecast at $21,161,529,166 and the highest earnings forecast at $23,406,737,357.

What is ABBV's revenue growth forecast for 2022-2024?

(NYSE: ABBV) AbbVie's forecast annual revenue growth rate of 0.22% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.5%.

AbbVie's revenue in 2022 is $55,169,000,000.On average, 4 Wall Street analysts forecast ABBV's revenue for 2022 to be $105,872,512,900,272, with the lowest ABBV revenue forecast at $104,845,918,857,290, and the highest ABBV revenue forecast at $106,823,222,442,174. On average, 4 Wall Street analysts forecast ABBV's revenue for 2023 to be $99,514,327,272,138, with the lowest ABBV revenue forecast at $98,573,867,901,172, and the highest ABBV revenue forecast at $100,896,473,898,480.

In 2024, ABBV is forecast to generate $100,175,178,668,760 in revenue, with the lowest revenue forecast at $98,957,109,028,375 and the highest revenue forecast at $101,393,248,309,145.

What is ABBV's forecast return on assets (ROA) for 2022-2025?

(NYSE: ABBV) forecast ROA is 15.95%, which is lower than the forecast US Drug Manufacturers - General industry average of 17.32%.

What is ABBV's Price Target?

According to 8 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $145.88, with the highest ABBV stock price forecast at $172.00 and the lowest ABBV stock price forecast at $113.00.

On average, Wall Street analysts predict that AbbVie's share price could reach $145.88 by Jan 24, 2023. The average AbbVie stock price prediction forecasts a potential upside of 5.77% from the current ABBV share price of $137.92.

What is ABBV's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: ABBV) AbbVie's current Earnings Per Share (EPS) is $4.15. On average, analysts forecast that ABBV's EPS will be $14.07 for 2022, with the lowest EPS forecast at $13.88, and the highest EPS forecast at $14.50. On average, analysts forecast that ABBV's EPS will be $12.21 for 2023, with the lowest EPS forecast at $11.83, and the highest EPS forecast at $12.73. In 2024, ABBV's EPS is forecast to hit $12.61 (min: $11.97, max: $13.24).

What is ABBV's forecast return on equity (ROE) for 2022-2025?

(NYSE: ABBV) forecast ROE is 175.18%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.